Innoblative SIRA RFA Gets FDA Breakthrough Device Designation
Innoblative's SIRA RFA Electrosurgical Device is intended for use in breast cancer patients undergoing BCS.
Innoblative's SIRA RFA Electrosurgical Device is intended for use in breast cancer patients undergoing BCS.
Computer algorithms analyzing digital pathology slide images were shown to detect the spread of cancer to lymph nodes in women with breast cancer as well as or better than pathologists, in a new study published online in the Journal of the American Medical Association.
Innoblative's SIRA RFA Electrosurgical Device is intended for use in breast cancer patients undergoing BCS.